Safilo Group SpASAFLF 62 ROA % is 1.79% as of Dec. 2025. GuruFocus rates SAFLF with a GF Score™ of 62/100 and a GF Value™ of $1.24 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 857 Medical Devices & Instruments companies, Safilo Group SpA ranks better than 74.1% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Safilo Group SpA's annualizedNet Income for the quarter that ended in Dec. 2025 was $16 Mil.
Safilo Group SpA's average Total Assets over the quarter that ended in Dec. 2025 was $906 Mil. Therefore, Safilo Group SpA's annualized ROA % for the quarter that ended in Dec. 2025 was 1.79%.
The historical rank and industry rank for Safilo Group SpA's ROA % or its related term are showing as below:
SAFLF'
s ROA % Range Over the Past 10 Years
Min: -32.52 Med: -2.74 Max: 6.07
Current: 6.07
During the past 13 years, Safilo Group SpA's highest ROA % was 6.07%. The lowest was -32.52%. And the median was -2.74%.
SAFLF's ROA % is ranked better than 74.1% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.59
vs SAFLF: 6.07
Safilo Group SpA (OTCPK:SAFLF) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Safilo Group SpA ROA % Related Terms
Safilo Group SpA ROA % Historical Data
* Premium members only.
The historical data trend for Safilo Group SpA's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Safilo Group SpA's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Safilo Group SpA ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Safilo Group SpA's ROA % distribution charts can be found below:
* The bar in red indicates where Safilo Group SpA's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Safilo Group SpA (SAFLF) has a ROA % of 1.79% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Safilo Group SpA and its competitors. According to the industry distribution chart, Safilo Group SpA ranks #222 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 25.9%.
Is Safilo Group SpA's ROA % too high?
Safilo Group SpA's current ROA % is 1.79%. The Medical Devices & Instruments industry median ROA % is 0.59. Safilo Group SpA's value of 1.79% is 203.4% above this industry median. Based on the distribution chart, Safilo Group SpA ranks #222 out of 857 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Safilo Group SpA has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Safilo Group SpA's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Safilo Group SpA ranks #222 out of 857 companies for ROA %. This puts Safilo Group SpA in the upper half of its industry. The industry median ROA % is 0.59. Safilo Group SpA's value of 1.79% is 203.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.59, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Safilo Group SpA's current ROA % of 1.79% is 203.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Safilo Group SpA and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Safilo Group SpA's current ROA % is 1.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Safilo Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Safilo Group SpA (SAFLF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.24, compared to a current price of $2.01 — trading 62.1% above its estimated fair value. The current ROA % is 1.79% and 203.4% above the Medical Devices & Instruments industry median of 0.59. Safilo Group SpA's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Safilo Group SpA (SAFLF), the current ROA % is 1.79% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Safilo Group SpA (SAFLF) Overvalued in 2026?
Based on GuruFocus' analysis, Safilo Group SpA stock appears to be overvalued.
The current stock price of $2.01 is trading 62.1% above its estimated GF Value™ of $1.24.
GuruFocus considers Safilo Group SpA to be Significantly Overvalued.
Key valuation signals for SAFLF:
ROA %: 1.79%
GF Value™: $1.24 vs. price of $2.01 (62.1% above fair value)
Industry Position: 203.4% above the Medical Devices & Instruments median (#222 of 857)
No single metric tells the full story. See the SAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Safilo Group SpA makes sunglasses and prescription eyewear. It is engaged in design, production, and wholesale distribution of its products through a network of independent distributors and commercial subsidiaries. Its products are sold through the Carrera, Smith, Polaroid and Oxydo brands, as well as a range of other licensed brands. The company operates solely through the wholesale segment channels and divides itself into the following four geographical segments: Europe, America, and Asia. The company earns the majority of its revenue from the Europe business segment.
62GF Score
Get the complete analysis for SAFLF
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAFLF has been successfully added to your 
